Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph G Joyce

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|November 24, 2016
Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing AntibodiesSannula Kesavardhana, Raksha Das, Michael Citron, et al.
The Journal of Biological Chemistry|June 23, 2006
Structure-function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107IVirginie Bernier, Rino Stocco, Michael J Bogusky, et al.
Vaccine|December 24, 2022
Preclinical evaluation of an investigational 21-valent pneumococcal conjugate vaccine, V116, in adult-rhesus monkey, rabbit, and mouse modelsStephanie Curry, Robin M Kaufhold, Morgan A Monslow, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challengeGayathri Bommakanti, Michael P Citron, Robert W Hepler, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2008
An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virionsJoseph G Joyce, Isaac J Krauss, Hong C Song, et al.
The Journal of Biological Chemistry|October 15, 2010
Small molecule mimetics of an HIV-1 gp41 fusion intermediate as vaccine leadsMichael J Caulfield, Vadim Y Dudkin, Elizabeth A Ottinger, et al.
Mabs|May 22, 2015
Efficient generation of monoclonal antibodies from single rhesus macaque antibody secreting cellsWeixu Meng, Leike Li, Wei Xiong, et al.
Vaccine|March 26, 2014
Development of a recombinant toxin fragment vaccine for Clostridium difficile infectionJerzy Karczewski, Julie Zorman, Su Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2010
Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolatesElisabetta Bianchi, Joseph G Joyce, Michael D Miller, et al.
Vaccine|November 8, 2005
A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infectionRobert W Hepler, Rosemarie Kelly, Tessie B McNeely, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|November 24, 2016
Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing AntibodiesSannula Kesavardhana, Raksha Das, Michael Citron, et al.
The Journal of Biological Chemistry|June 23, 2006
Structure-function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107IVirginie Bernier, Rino Stocco, Michael J Bogusky, et al.
Vaccine|December 24, 2022
Preclinical evaluation of an investigational 21-valent pneumococcal conjugate vaccine, V116, in adult-rhesus monkey, rabbit, and mouse modelsStephanie Curry, Robin M Kaufhold, Morgan A Monslow, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challengeGayathri Bommakanti, Michael P Citron, Robert W Hepler, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2008
An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virionsJoseph G Joyce, Isaac J Krauss, Hong C Song, et al.
The Journal of Biological Chemistry|October 15, 2010
Small molecule mimetics of an HIV-1 gp41 fusion intermediate as vaccine leadsMichael J Caulfield, Vadim Y Dudkin, Elizabeth A Ottinger, et al.
Mabs|May 22, 2015
Efficient generation of monoclonal antibodies from single rhesus macaque antibody secreting cellsWeixu Meng, Leike Li, Wei Xiong, et al.
Vaccine|March 26, 2014
Development of a recombinant toxin fragment vaccine for Clostridium difficile infectionJerzy Karczewski, Julie Zorman, Su Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2010
Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolatesElisabetta Bianchi, Joseph G Joyce, Michael D Miller, et al.
Vaccine|November 8, 2005
A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infectionRobert W Hepler, Rosemarie Kelly, Tessie B McNeely, et al.
Pageof 4